期刊名：Livers

期刊主页： https://www.mdpi.com/journal/livers

本期编辑荐读为您精选Livers期刊中10篇2024–2025年热门高访问论文，旨在为肝病学领域的各位专家学者分享广受关注的研究进展，启发研究思路。

1. Herbal- and Dietary-Supplement-Induced Liver Injury: A Review of the Recent Literature

草本及膳食补充剂引起的肝损伤：近期文献综述

https://www.mdpi.com/2673-4389/4/1/8

Patel-Rodrigues, P.A.; Cundra, L.; Alhaqqan, D.; Gildea, D.T.; Woo, S.M.; Lewis, J.H. Herbal- and Dietary-Supplement-Induced Liver Injury: A Review of the Recent Literature. Livers 2024, 4, 94–118. https://doi.org/10.3390/livers4010008

2. Liver Cirrhosis: Evolving Definitions, and Recent Advances in Diagnosis, Prevention and Management

肝硬化：定义的演变及诊断、预防与管理方面的最新进展

https://www.mdpi.com/2673-4389/5/3/28

Battle, A.; Mudd, J.; Ahlenstiel, G.; Kalo, E. Liver Cirrhosis: Evolving Definitions, and Recent Advances in Diagnosis, Prevention and Management. Livers 2025, 5, 28. https://doi.org/10.3390/livers5030028

3. Hepatotoxicity of Herbal and Dietary Supplements a Review of Diagnosis, Histologic Features, and Common Culprits: Bodybuilding and Weight Loss Supplements

草本及膳食补充剂的肝毒性：诊断、组织学特征及常见致病产品综述——健美与减肥补充剂

https://www.mdpi.com/2673-4389/5/3/42

Marginean, E.C. Hepatotoxicity of Herbal and Dietary Supplements a Review of Diagnosis, Histologic Features, and Common Culprits: Bodybuilding and Weight Loss Supplements. Livers 2025, 5, 42. https://doi.org/10.3390/livers5030042

4. Applicability of Statins in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

他汀类药物在代谢功能障碍相关脂肪性肝病（MASLD）中的适用性

https://www.mdpi.com/2673-4389/5/1/4

Prasoppokakorn, T. Applicability of Statins in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). Livers 2025, 5, 4. https://doi.org/10.3390/livers5010004

5. Acetylcysteine Treatment of Acetaminophen Overdose: Foundational and Clinical Development

乙酰半胱氨酸治疗对乙酰氨基酚过量：基础与临床开发

https://www.mdpi.com/2673-4389/5/2/20

Rumack, B.H. Acetylcysteine Treatment of Acetaminophen Overdose: Foundational and Clinical Development. Livers 2025, 5, 20. https://doi.org/10.3390/livers5020020

6. Deciphering the Gut–Liver Axis: A Comprehensive Scientific Review of Non-Alcoholic Fatty Liver Disease

解读肠-肝轴：非酒精性脂肪性肝病的全面科学综述

https://www.mdpi.com/2673-4389/4/3/32

Singh, S.; Kriti, M.; Catanzaro, R.; Marotta, F.; Malvi, M.; Jain, A.; Verma, V.; Nagpal, R.; Tiwari, R.; Kumar, M. Deciphering the Gut–Liver Axis: A Comprehensive Scientific Review of Non-Alcoholic Fatty Liver Disease. Livers 2024, 4, 435–454. https://doi.org/10.3390/livers4030032

7. Cutaneous Manifestations of Liver Cirrhosis: Clinical Significance and Diagnostic Implications

肝硬化的皮肤表现：临床意义与诊断启示

https://www.mdpi.com/2673-4389/5/3/37

Kamoua, R.; Reese, R.; Annamraju, R.; Chen, T.; Doyle, C.; Parella, A.; Liu, A.; Abboud, Y.; Rohan, C.; Travers, J.B. Cutaneous Manifestations of Liver Cirrhosis: Clinical Significance and Diagnostic Implications. Livers 2025, 5, 37. https://doi.org/10.3390/livers5030037

8. Gut Microbiota and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Emerging Pathogenic Mechanisms and Therapeutic Implications

肠道菌群与代谢功能障碍相关脂肪变性肝病（MASLD）：新兴致病机制及治疗启示

https://www.mdpi.com/2673-4389/5/1/11

Abdelhameed, F.; Mustafa, A.; Kite, C.; Lagojda, L.; Dallaway, A.; Than, N.N.; Kassi, E.; Kyrou, I.; Randeva, H.S. Gut Microbiota and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Emerging Pathogenic Mechanisms and Therapeutic Implications. Livers 2025, 5, 11. https://doi.org/10.3390/livers5010011

9. Lobar and Segmental Atrophy of the Liver: Differential Diagnoses and Treatments

肝脏叶段萎缩：鉴别诊断与治疗

https://www.mdpi.com/2673-4389/4/3/23

Ferraina, F.; Fogliati, A.; Scotti, M.A.; Romano, F.; Garancini, M.; Ciulli, C. Lobar and Segmental Atrophy of the Liver: Differential Diagnoses and Treatments. Livers 2024, 4, 320–332. https://doi.org/10.3390/livers4030023

10. The Epidemiology of Chronic Hepatitis C: Where We Are Now

慢性丙型肝炎的流行病学：现状与进展

https://www.mdpi.com/2673-4389/4/2/13

Stasi, C.; Milli, C.; Voller, F.; Silvestri, C. The Epidemiology of Chronic Hepatitis C: Where We Are Now. Livers 2024, 4, 172–181. https://doi.org/10.3390/livers4020013

相关会议

Biomarkers in Drug-Induced Liver Injury

会议时间：2026 年 9月 16 日 15:00-17:00 CEST（北京时间 21:00-23:00）

会议形式：英文线上会议

会议官网：https://sciforum.net/event/LIVERS-3

学者招募

Livers期刊青年编委招募招募

招募人数：30名

报名截止时间：2027年2月28日

点击链接，了解更多招募信息：https://www.mdpi.com/about/announcements/17529

期刊介绍

期刊主编：Prof. Dr. Hartmut W. Jaeschke

University of Kansas Medical Center, Kansas City, KS 66160, USA

Livers (ISSN: 2673-4389)是一个国际型开放获取英文学术期刊，期刊主题涵盖所有形式的肝炎，酒精性肝病，非酒精性脂肪性肝病和非酒精性脂性肝炎，肝硬化，胆道疾病，药物性肝损伤，遗传性和代谢性肝病及其并发症，癌症与药物代谢，肝细胞癌，肝纤维化，肝病免疫学，肝病学营养，肝病病理学，肝病的诊断和治疗。为肝病学多学科领域的基础、转化和高级临床研究提供平台。

2025 Impact Factor：2.2

2025 CiteScore：4.1

Time to First Decision：28天

Acceptance to Publication：10.9天